JOHN GIBBONS: Open Payments
NPI 1902398845 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$274 in 14 payments from 7 companies in 2025. Trend: 2023 $209 · 2024 $126 · 2025 $274
Food & beverage: $274
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $89 |
| Merz Pharmaceuticals, LLC | 4 | $72 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Octapharma USA, Inc. | 1 | $27 |
| Valinor Pharma, LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Tonix Medicines, Inc. | 1 | $15 |
Products named: BOTOX, Xeomin, Belbuca, OCTAGAM IMMUNE GLOBULIN (HUMAN), MOVANTIK, LOREEV XR, TONMYA.
Industry payments across IN — which companies pay providers there.
